Effects of ginger extract and its major component 6-gingerol on anti-tumor property through mitochondrial biogenesis in CD8+ T cells

被引:16
|
作者
Deng, Xiaohong [1 ]
Chen, Dandan [1 ]
Sun, Xianjun [1 ]
Dong, Jingcheng [1 ]
Huang, Jianhua [1 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Integrat Med, Shanghai, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
cancer; ginger; mitochondrial biogenesis; T cells; ZINGIBER-OFFICINALE ROSCOE; ACTIVATION; PHYTOCHEMICALS; LYMPHOCYTES; METABOLISM; SYNERGY;
D O I
10.1111/1750-3841.16228
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Ginger extract (GE) and its major component 6-gingerol (6G) have been reported to exert anti-tumor effects in various cancers. The underlying mechanism, however, has not been well demonstrated. Here, we have focused on the relationship between promotion of mitochondrial biogenesis in tumor infiltrating CD8(+) T cells induced by GE and 6G and their cytotoxic effect. The results showed that GE induced 56% inhibition of tumor growth in Lewis lung carcinoma (LLC) xenograft mouse model and 6G induced 33% (25 mg/kg) and 37% (50 mg/kg) inhibition. GE increased mitochondrial mass of CD8(+) T cells in tumor and draining lymph nodes (DLNs) significantly, while 6G had no significant effect. GE and 6G both had no significant influence on histopathological changes of liver and kidney in mice. In the co-culture system of CTLL-2 cells and LLC cells, GE enhanced the cytotoxicity of CTLL-2 cells against LLC cells by 14% and 19% at concentrations of 2.5 and 5 mg/ml, respectively. 6G did not promote cytotoxicity of CTLL-2 cells. GE increased mitochondrial mass at 5 and 10 mg/ml and mtDNA copy number and ATP production at 2.5, 5, 10 mg/ml in CTLL-2 cells. 6G promoted mtDNA copy number at 50, 100, 150 mu M and mitochondrial mass and ATP production at 25, 50, 100, 150 mu M in CTLL-2 cells. These results suggest that promotion of mitochondrial biogenesis and function in tumor infiltrating CD8(+) T cells may play an essential role in GE-induced inhibition of tumor growth. The current results perfect the mechanism of anti-tumor effect of ginger, which is beneficial for further application in cancer management. Practical Application Ginger, as a worldwide food seasoning and herbal medicine in traditional Chinese medicine, has been reported to possess anti-tumor efficacy. To our knowledge, it is the first time to focus on ginger's ability of promoting mitochondrial biogenesis in tumor infiltrating CD8(+) T cells to explore the mechanism of its anti-tumor effect. Our observations demonstrate that ginger inhibits tumor growth via promoting mitochondrial biogenesis and function of T cells. The present study links food to anti-tumor immunity and provides impetus to investigate and design dietary supplements for cancer management.
引用
收藏
页码:3307 / 3317
页数:11
相关论文
共 50 条
  • [1] Promotion of Mitochondrial Biogenesis via Activation of AMPK-PGC1&x251; Signaling Pathway by Ginger (Zingiber officinale Roscoe) Extract, and Its Major Active Component 6-Gingerol
    Deng, Xiaohong
    Zhang, Siwei
    Wu, Junzhen
    Sun, Xianjun
    Shen, Ziyin
    Dong, Jingcheng
    Huang, Jianhua
    JOURNAL OF FOOD SCIENCE, 2019, 84 (08) : 2101 - 2111
  • [2] Palmitoylated antigens for the induction of anti-tumor CD8+ T cells and enhanced tumor recognition
    Stolk, Dorian A.
    Horrevorts, Sophie K.
    Schetters, Sjoerd T. T.
    Kruijssen, Laura J. W.
    Duinkerken, Sanne
    Keuning, Eelco
    Ambrosini, Martino
    Kalay, Hakan
    van de Ven, Rieneke
    Garcia-Vallejo, Juan J.
    de Gruijl, Tanja D.
    van Vliet, Sandra J.
    van Kooyk, Yvette
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 21 : 315 - 328
  • [3] High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells
    Li, Jing
    He, Yi
    Hao, Jing
    Ni, Ling
    Dong, Chen
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [4] Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing
    MacNabb, Brendan W.
    Tumuluru, Sravya
    Chen, Xiufen
    Godfrey, James
    Kasal, Darshan N.
    Yu, Jovian
    Jongsma, Marlieke L. M.
    Spaapen, Robbert M.
    Kline, Douglas E.
    Kline, Justin
    IMMUNITY, 2022, 55 (06) : 982 - +
  • [5] Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells
    Matas-Rico, Elisa
    Frijlink, Elselien
    Avila, Irene van der Haar
    Menegakis, Apostolos
    van Zon, Maaike
    Morris, Andrew J.
    Koster, Jan
    Salgado-Polo, Fernando
    de Kivit, Sander
    Lanc, Telma
    Mazzocca, Antonio
    Johnson, Zoe
    Haanen, John
    Schumacher, Ton N.
    Perrakis, Anastassis
    Verbrugge, Inge
    van den Berg, Joost H.
    Borst, Jannie
    Moolenaar, Wouter H.
    CELL REPORTS, 2021, 37 (07):
  • [6] A nanobody against CTLA-4 increases the anti-tumor effects of specific CD8+ T cells
    Mo, F.
    Liang, L.
    Yang, X.
    Liu, A.
    Yin, S.
    Lu, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1809 - 1809
  • [7] In vivo trafficking of naive and activated anti-tumor transgenic CD8+ T-cells
    Matsui, K
    Allen, PM
    FASEB JOURNAL, 2001, 15 (04): : A661 - A661
  • [8] HMGN2, a new anti-tumor effector molecule of CD8+ T cells
    Lin Su
    Ankang Hu
    Yang Luo
    Wenjie Zhou
    Ping Zhang
    Yun Feng
    Molecular Cancer, 13
  • [9] Blockade of 6-phosphogluconate dehydrogenase generates CD8+ effector T cells with enhanced anti-tumor function
    Daneshmandi, Saeed
    Cassel, Teresa
    Lin, Penghui
    Higashi, Richard M.
    Wulf, Gerburg M.
    Boussiotis, Vassiliki A.
    Fan, Teresa W-M
    Seth, Pankaj
    CELL REPORTS, 2021, 34 (10):
  • [10] HMGN2, a new anti-tumor effector molecule of CD8+ T cells
    Su, Lin
    Hu, Ankang
    Luo, Yang
    Zhou, Wenjie
    Zhang, Ping
    Feng, Yun
    MOLECULAR CANCER, 2014, 13